(Q36677487)

15 August 2017

1 reference

title

Multiple biomarker panels for early detection of ovarian cancer (English)

1 reference

15 August 2017

0 references

1 reference

Zoya R Yurkovetsky

1

1 reference

15 August 2017

Faina Y Linkov

series ordinal

2

1 reference

15 August 2017

David E Malehorn

series ordinal

3

1 reference

15 August 2017

Anna E Lokshin

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

733-741

1 reference

Screening for ovarian cancer

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Ovarian cancer screening in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Progress and challenges in screening for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Expression of cadherins and CD44 isoforms in ovarian endometrial cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Ultrasound Screening for the Early Detection of Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Elevation of multiple serum markers in patients with stage I ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Screening for ovarian cancer: a pilot randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Status of Tumor Markers in Ovarian Cancer Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Interleukin-6 serum levels in patients with gynecological tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Preoperative serum inhibin levels in patients with ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Inhibins and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Detection of cancer-specific markers amid massive mass spectral data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Clinical potential of proteomics in the diagnosis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Proteomic analysis for early detection of ovarian cancer: a realistic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Clinical proteomics and biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.733

21 January 2018

Identifiers

DOI

10.2217/14796694.2.6.733

1 reference

15 August 2017

1 reference